InterCure Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Alex Rabinovich
Chief executive officer
₪1.4m
Total compensation
| CEO salary percentage | 51.5% |
| CEO tenure | 5.9yrs |
| CEO ownership | 26.6% |
| Management average tenure | no data |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
Jun 30InterCure: Bargain Israel Cannabis Play
Apr 22InterCure: A Leader In Global Cannabis
Sep 06InterCure reports Q2 results
Aug 15InterCure Is Growing In The Massive Global Cannabis Market
Jun 07IntureCure: Israel Recreation Cannabis Boom On The Way
Feb 16InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)
Nov 08InterCure: Internationally Profitable Cannabis (Podcast Transcript)
Sep 19InterCure: Ignored Uplisting
Sep 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -₪66m |
| Mar 31 2024 | n/a | n/a | -₪61m |
| Dec 31 2023 | ₪1m | ₪728k | -₪62m |
| Sep 30 2023 | n/a | n/a | -₪20m |
| Jun 30 2023 | n/a | n/a | ₪21m |
| Mar 31 2023 | n/a | n/a | ₪32m |
| Dec 31 2022 | ₪1m | ₪500k | ₪45m |
| Sep 30 2022 | n/a | n/a | ₪33m |
| Jun 30 2022 | n/a | n/a | ₪24m |
| Mar 31 2022 | n/a | n/a | ₪15m |
| Dec 31 2021 | ₪180k | ₪180k | ₪5m |
| Sep 30 2021 | n/a | n/a | ₪17m |
| Jun 30 2021 | n/a | n/a | ₪20m |
| Mar 31 2021 | n/a | n/a | ₪13m |
| Dec 31 2020 | ₪122k | ₪122k | -₪37m |
Compensation vs Market: Alex's total compensation ($USD387.61K) is below average for companies of similar size in the US market ($USD651.40K).
Compensation vs Earnings: Alex's compensation has increased whilst the company is unprofitable.
CEO
Alex Rabinovich (53 yo)
5.9yrs
Tenure
₪1,414,000
Compensation
Mr. Alexander Rabinovich, also known as Alex, is Chief Executive Officer and Director of InterCure Ltd. since January 1, 2019 and October 2018 respectively. Mr. Rabinovich is Chief Executive Officer and Di...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 6.2yrs | ₪1.41m | 26.58% $ 21.3m | |
| Chairman of the Board | 6.3yrs | ₪445.00k | 2.25% $ 1.8m | |
| Non-Executive Director | 4.1yrs | ₪152.00k | no data | |
| Independent Director | 10yrs | ₪201.00k | 0.0088% $ 7.1k | |
| Independent External Director | 9.3yrs | ₪201.00k | 0.024% $ 18.9k | |
| Independent External Director | 6.3yrs | ₪201.00k | 0.0088% $ 7.1k |
6.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: INCR's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 00:49 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InterCure Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matt Bottomley | Canaccord Genuity |
| Vivien Azer | TD Cowen |